vs
CSW INDUSTRIALS, INC.(CSW)とブリストル・マイヤーズスクイブ(MYE)の財務データ比較。上の社名をクリックして会社を切り替えられます
CSW INDUSTRIALS, INC.の直近四半期売上が大きい($233.0M vs $204.0M、ブリストル・マイヤーズスクイブの約1.1倍)。ブリストル・マイヤーズスクイブの純利益率が高く(5.6% vs 4.4%、差は1.2%)。CSW INDUSTRIALS, INC.の前年同期比売上増加率が高い(20.3% vs 0.0%)。CSW INDUSTRIALS, INC.の直近四半期フリーキャッシュフローが多い($22.7M vs $18.9M)。過去8四半期でCSW INDUSTRIALS, INC.の売上複合成長率が高い(5.1% vs -0.8%)
ブリストル・マイヤーズ スクイブは米国ニュージャージー州プリンストンに本社を置く多国籍製薬企業です。不整脈治療薬のアピキサバン(商品名エリクイス)、各種がん治療薬のニボルマブ(商品名オプジーボ)、多発性骨髄腫治療薬のレナリドミド(商品名レブリミド)などを主力製品としています。
CSW vs MYE — 直接比較
売上が大きい
CSW
1.1倍大きい
$204.0M
売上成長率が高い
CSW
+20.3%の差
0.0%
純利益率が高い
MYE
純利益率が1.2%高い
4.4%
フリーキャッシュフローが多い
CSW
FCF $3.8M多い
$18.9M
2年売上CAGRが高い
CSW
2年複合成長率
-0.8%
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $233.0M | $204.0M |
| 純利益 | $10.3M | $11.3M |
| 粗利率 | 39.7% | 33.2% |
| 営業利益率 | 7.4% | 9.9% |
| 純利益率 | 4.4% | 5.6% |
| 売上前年比 | 20.3% | 0.0% |
| 純利益前年比 | -61.9% | 163.7% |
| EPS(希薄化後) | $0.62 | $0.30 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上
CSW
MYE
| Q4 25 | $233.0M | $204.0M | ||
| Q3 25 | $277.0M | $205.4M | ||
| Q2 25 | $263.6M | $209.6M | ||
| Q1 25 | $230.5M | $206.8M | ||
| Q4 24 | $193.6M | $203.9M | ||
| Q3 24 | $227.9M | $205.1M | ||
| Q2 24 | $226.2M | $220.2M | ||
| Q1 24 | $210.9M | $207.1M |
純利益
CSW
MYE
| Q4 25 | $10.3M | $11.3M | ||
| Q3 25 | $40.7M | $7.1M | ||
| Q2 25 | $40.9M | $9.7M | ||
| Q1 25 | $35.1M | $6.8M | ||
| Q4 24 | $26.9M | $4.3M | ||
| Q3 24 | $36.1M | $-10.9M | ||
| Q2 24 | $38.6M | $10.3M | ||
| Q1 24 | $31.8M | $3.5M |
粗利率
CSW
MYE
| Q4 25 | 39.7% | 33.2% | ||
| Q3 25 | 43.0% | 33.4% | ||
| Q2 25 | 43.8% | 33.7% | ||
| Q1 25 | 44.2% | 33.4% | ||
| Q4 24 | 41.4% | 32.3% | ||
| Q3 24 | 45.6% | 31.8% | ||
| Q2 24 | 47.5% | 34.3% | ||
| Q1 24 | 44.4% | 31.0% |
営業利益率
CSW
MYE
| Q4 25 | 7.4% | 9.9% | ||
| Q3 25 | 20.5% | 8.6% | ||
| Q2 25 | 20.8% | 9.5% | ||
| Q1 25 | 19.5% | 8.1% | ||
| Q4 24 | 15.3% | 7.2% | ||
| Q3 24 | 22.6% | -2.3% | ||
| Q2 24 | 24.3% | 10.8% | ||
| Q1 24 | 21.0% | 5.3% |
純利益率
CSW
MYE
| Q4 25 | 4.4% | 5.6% | ||
| Q3 25 | 14.7% | 3.5% | ||
| Q2 25 | 15.5% | 4.6% | ||
| Q1 25 | 15.2% | 3.3% | ||
| Q4 24 | 13.9% | 2.1% | ||
| Q3 24 | 15.8% | -5.3% | ||
| Q2 24 | 17.1% | 4.7% | ||
| Q1 24 | 15.1% | 1.7% |
EPS(希薄化後)
CSW
MYE
| Q4 25 | $0.62 | $0.30 | ||
| Q3 25 | $2.41 | $0.19 | ||
| Q2 25 | $2.43 | $0.26 | ||
| Q1 25 | $2.05 | $0.18 | ||
| Q4 24 | $1.60 | $0.11 | ||
| Q3 24 | $2.26 | $-0.29 | ||
| Q2 24 | $2.47 | $0.28 | ||
| Q1 24 | $2.03 | $0.09 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $40.2M | $45.0M |
| 総負債低いほど良い | — | $345.8M |
| 株主資本純資産 | $1.1B | $294.2M |
| 総資産 | $2.3B | $851.3M |
| 負債/資本比率低いほどレバレッジが低い | — | 1.18× |
8四半期トレンド — 暦四半期で整列
現金・短期投資
CSW
MYE
| Q4 25 | $40.2M | $45.0M | ||
| Q3 25 | $31.5M | $48.0M | ||
| Q2 25 | $38.0M | $41.3M | ||
| Q1 25 | $225.8M | $35.3M | ||
| Q4 24 | $213.8M | $32.2M | ||
| Q3 24 | $273.2M | $29.7M | ||
| Q2 24 | $18.9M | $37.3M | ||
| Q1 24 | $22.2M | $32.7M |
総負債
CSW
MYE
| Q4 25 | — | $345.8M | ||
| Q3 25 | — | $361.2M | ||
| Q2 25 | — | $370.8M | ||
| Q1 25 | $800.1M | $383.4M | ||
| Q4 24 | — | $375.0M | ||
| Q3 24 | — | $387.5M | ||
| Q2 24 | — | $400.1M | ||
| Q1 24 | $166.0M | $400.6M |
株主資本
CSW
MYE
| Q4 25 | $1.1B | $294.2M | ||
| Q3 25 | $1.1B | $286.6M | ||
| Q2 25 | $1.1B | $284.6M | ||
| Q1 25 | $1.1B | $277.4M | ||
| Q4 24 | $1.0B | $277.5M | ||
| Q3 24 | $1.0B | $275.6M | ||
| Q2 24 | $650.2M | $294.6M | ||
| Q1 24 | $615.7M | $291.7M |
総資産
CSW
MYE
| Q4 25 | $2.3B | $851.3M | ||
| Q3 25 | $1.5B | $864.1M | ||
| Q2 25 | $1.5B | $862.7M | ||
| Q1 25 | $1.4B | $883.8M | ||
| Q4 24 | $1.4B | $860.8M | ||
| Q3 24 | $1.4B | $905.0M | ||
| Q2 24 | $1.1B | $951.6M | ||
| Q1 24 | $1.0B | $947.1M |
負債/資本比率
CSW
MYE
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.30× | ||
| Q1 25 | 0.75× | 1.38× | ||
| Q4 24 | — | 1.35× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | 0.27× | 1.37× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.9M | $22.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $22.7M | $18.9M |
| FCFマージンFCF / 売上 | 9.8% | 9.3% |
| 設備投資強度設備投資 / 売上 | 2.6% | 1.8% |
| キャッシュ転換率営業CF / 純利益 | 2.81× | 1.99× |
| 直近12ヶ月FCF直近4四半期 | $162.0M | $67.2M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフロー
CSW
MYE
| Q4 25 | $28.9M | $22.6M | ||
| Q3 25 | $61.8M | $25.8M | ||
| Q2 25 | $60.6M | $28.3M | ||
| Q1 25 | $27.3M | $10.1M | ||
| Q4 24 | $11.6M | $27.3M | ||
| Q3 24 | $66.8M | $17.3M | ||
| Q2 24 | $62.7M | $14.3M | ||
| Q1 24 | $22.4M | $20.3M |
フリーキャッシュフロー
CSW
MYE
| Q4 25 | $22.7M | $18.9M | ||
| Q3 25 | $58.7M | $21.5M | ||
| Q2 25 | $57.7M | $24.7M | ||
| Q1 25 | $22.8M | $2.0M | ||
| Q4 24 | $8.5M | $20.2M | ||
| Q3 24 | $61.3M | $10.1M | ||
| Q2 24 | $59.6M | $9.9M | ||
| Q1 24 | $17.5M | $14.6M |
FCFマージン
CSW
MYE
| Q4 25 | 9.8% | 9.3% | ||
| Q3 25 | 21.2% | 10.5% | ||
| Q2 25 | 21.9% | 11.8% | ||
| Q1 25 | 9.9% | 1.0% | ||
| Q4 24 | 4.4% | 9.9% | ||
| Q3 24 | 26.9% | 4.9% | ||
| Q2 24 | 26.3% | 4.5% | ||
| Q1 24 | 8.3% | 7.0% |
設備投資強度
CSW
MYE
| Q4 25 | 2.6% | 1.8% | ||
| Q3 25 | 1.1% | 2.1% | ||
| Q2 25 | 1.1% | 1.7% | ||
| Q1 25 | 2.0% | 3.9% | ||
| Q4 24 | 1.6% | 3.5% | ||
| Q3 24 | 2.4% | 3.5% | ||
| Q2 24 | 1.4% | 2.0% | ||
| Q1 24 | 2.3% | 2.8% |
キャッシュ転換率
CSW
MYE
| Q4 25 | 2.81× | 1.99× | ||
| Q3 25 | 1.52× | 3.63× | ||
| Q2 25 | 1.48× | 2.92× | ||
| Q1 25 | 0.78× | 1.49× | ||
| Q4 24 | 0.43× | 6.36× | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | 1.40× | ||
| Q1 24 | 0.71× | 5.79× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
MYE
| Industrial | $64.3M | 32% |
| Auto Aftermarket | $51.7M | 25% |
| Infrastructure | $34.0M | 17% |
| Food And Beverage | $23.2M | 11% |
| Vehicle | $17.9M | 9% |
| Consumer | $12.9M | 6% |